Go to main content
Back to Back to integrum.se

First surgery in Germany with the OPRA™ implant system

For the first time a patient in Germany has undergone surgery with Integrum’s OPRA bone anchored implant system. The surgery was carried out at University Medical Center in Göttingen.

The 55-year-old patient lost his right arm in a work-related accident 14 years ago. Although fitted with an assistive device, the patient only occasionally used the arm prosthesis and eventually not at all. Looking for alternatives the patient decided to get an OPRA implant. In the surgery, the bone anchored OPRA implant was combined with a new procedure, “Targeted Muscle Reinnervation”, (TMR) where "unemployed" nerve stumps are transferred to remaining muscles of the residual limb. The combination of bone anchored OPRA implant and TMR increases the comfort of the prosthesis, reduces phantom limb pain and offers completely new options for mind controlled prosthetic devices in the future.

“We at Integrum work with improving quality of life for amputee patients. This first surgery in Germany is a great example of what can be achieved and how our innovative implants and procedures are embraced by patients and surgeons”,
says Rutger Barrdahl, CEO. “

Rutger Barrdahl, CEO. Cell: +46 70 523 39 55, E-mail: rutger.barrdahl@integrum.se

Integrum provides innovative solutions for bone-anchored prostheses. Integrum’s OPRA™ implant system improves quality of life for amputees through higher prosthetic functionality, improved comfort and improved mobility. With 20 years’ experience from 500 surgeries in 14 countries, Integrum has today a leading position in bone anchored protheses. The company is publicly listed at Nasdaq Firth North.

Attachments
Release
Cookies

This website uses cookiesfor statistics and user experience.

This website uses cookies to improve your user experience, to provide a basis for improvement and further development of the website and to be able to direct more relevant offers to you.

Feel free to read our privacy policy. If you agree to our use, choose Allow all. If you want to change your choice afterwards, you will find that option at the bottom of the page.